4.6 Article

Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma

Related references

Note: Only part of the references are listed.
Article Oncology

Current treatment and recent progress in gastric cancer

Smita S. Joshi et al.

Summary: Gastric cancer is a common cause of cancer death worldwide, with treatment options including systemic chemotherapy, radiotherapy, surgery, immunotherapy, and targeted therapy. Classification and biomarkers for gastric cancer help in personalized therapy and identifying populations most likely to benefit from immunotherapy and targeted therapy.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Biochemistry & Molecular Biology

An angiogenesis-related long noncoding RNA signature correlates with prognosis in patients with hepatocellular carcinoma

Dengliang Lei et al.

Summary: A 5-lncRNA signature was constructed to accurately predict the prognosis of HCC patients and showed good performance in evaluations. The signature can be used for diagnostic purposes with the inclusion of relevant clinical information when constructing the nomogram.

BIOSCIENCE REPORTS (2021)

Article Oncology

Identification of a robust signature for clinical outcomes and immunotherapy response in gastric cancer: based on N6-methyladenosine related long noncoding RNAs

Tenghui Han et al.

Summary: This study systematically evaluated the expression of m(6)A regulators in gastric cancer patients and constructed a prognostic signature related to m(6)A and lncRNA, showing superior predictive capability for patient outcomes. The study found an intimate correlation between risk groups and tumor infiltrating cells, immune checkpoint expression, and response to immunotherapy. Furthermore, in vitro experiments validated the regulatory role of a specific lncRNA in migration and proliferation of gastric cancer cells.

CANCER CELL INTERNATIONAL (2021)

Article Genetics & Heredity

Construction on of a Ferroptosis-Related lncRNA-Based Model to Improve the Prognostic Evaluation of Gastric Cancer Patients Based on Bioinformatics

Jiahui Pan et al.

Summary: By analyzing ferroptosis-related lncRNAs, a gastric cancer prognostic signature model including 17 lncRNAs was constructed by the research team, improving survival prediction for gastric cancer patients. The model showed good predictive ability in prognosis evaluation.

FRONTIERS IN GENETICS (2021)

Article Oncology

Helicobacter pylori Infection-Related Long Non-Coding RNA Signatures Predict the Prognostic Status for Gastric Cancer Patients

Zhuoyuan Xin et al.

Summary: The study revealed the association between H. pylori infection and the condition of gastric cancer patients, suggesting the regulatory role of lncRNAs may affect patients' prognosis. A prognostic signature related to H. pylori infection based on lncRNAs was established and showed a strong correlation with the prognosis of patients infected with H. pylori.

FRONTIERS IN ONCOLOGY (2021)

Review Oncology

Long noncoding RNAs in cancer metastasis

S. John Liu et al.

Summary: Long noncoding RNAs play crucial roles in promoting metastasis by participating in discrete pro-metastatic steps and influencing the metastatic tumor microenvironment. They have the potential for diagnostic and therapeutic applications, but also face controversies and ongoing technical challenges. Further research is needed to explore their mechanisms and potential as targets for novel therapies in cancer metastasis.

NATURE REVIEWS CANCER (2021)

Review Oncology

RNA in cancer

Gregory J. Goodall et al.

Summary: Recent findings have shown that RNA processing is systematically altered in cancer, with mutations in RNA splicing factor genes and the shortening of 3' untranslated regions widely observed. Additionally, evidence suggests that other types of RNAs, including circular RNAs, can contribute to tumorigenesis.

NATURE REVIEWS CANCER (2021)

Review Biochemistry & Molecular Biology

Tumor angiogenesis: causes, consequences, challenges and opportunities

Roberta Lugano et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2020)

Article Biochemistry & Molecular Biology

Comprehensive analysis of dysregulated lncRNAs and their competing endogenous RNA network in triple-negative breast cancer

Leimarembi Devi Naorem et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)

Article Multidisciplinary Sciences

Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers

Yongsheng Li et al.

NATURE COMMUNICATIONS (2020)

Review Medicine, Research & Experimental

Roles of lncRNAs in cancer: Focusing on angiogenesis

Ke-Tao Jin et al.

LIFE SCIENCES (2020)

Review Oncology

Vessel co-option in cancer

Elizabeth A. Kuczynski et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Article Oncology

Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma

Virginia Di Paolo et al.

BMC CANCER (2018)

Review Biochemistry & Molecular Biology

Functional Classification and Experimental Dissection of Long Noncoding RNAs

Florian Kopp et al.

Editorial Material Cardiac & Cardiovascular Systems

Nomogram: An analogue tool to deliver digital knowledge

Seo Young Park

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2018)

Review Chemistry, Medicinal

LncRNA as a Therapeutic Target for Angiogenesis

Mohan M. Kumar et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)

Article Biochemistry & Molecular Biology

Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes

Razvan Cristescu et al.

NATURE MEDICINE (2015)

Article Multidisciplinary Sciences

Comprehensive molecular characterization of gastric adenocarcinoma

Adam J. Bass et al.

NATURE (2014)